Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2005 Feb;114(2):225-34.
doi: 10.1111/j.1365-2567.2004.02074.x.

Follicular dendritic cell dedifferentiation reduces scrapie susceptibility following inoculation via the skin

Affiliations

Follicular dendritic cell dedifferentiation reduces scrapie susceptibility following inoculation via the skin

Joanne Mohan et al. Immunology. 2005 Feb.

Abstract

Transmissible spongiform encephalopathies (TSEs) are a group of subacute infectious neurodegenerative diseases that are characterized by the accumulation in affected tissues of PrP(Sc), an abnormal isoform of the host prion protein (PrPc). Following peripheral exposure, TSE infectivity and PrP(Sc) usually accumulate in lymphoid tissues prior to neuroinvasion. Studies in mice have shown that exposure through scarified skin is an effective means of TSE transmission. Following inoculation via the skin, a functional immune system is critical for the transmission of TSEs to the brain, but until now, it has not been known which components of the immune system are required for efficient neuroinvasion. Temporary dedifferentiation of follicular dendritic cells (FDCs) by treatment with an inhibitor of the lymphotoxin-beta receptor signalling pathway (LTbetaR-Ig) 3 days before or 14 days after inoculation via the skin, blocked the early accumulation of PrP(Sc) and TSE infectivity within the draining lymph node. Furthermore, in the temporary absence of FDCs before inoculation, disease susceptibility was reduced and survival time significantly extended. Treatment with LTbetaR-Ig 14 days after TSE inoculation also significantly extended the disease incubation period. However, treatment 42 days after inoculation did not affect disease susceptibility or survival time, suggesting that the infection may have already have spread to the nervous system. Together these data show that FDCs are essential for the accumulation of PrP(Sc) and infectivity within lymphoid tissues and subsequent neuroinvasion following TSE exposure via the skin.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Effect of treatment with lymphotoxin β-receptor immunoglobulin (LTβR-Ig) on follicular dendritic cell (FDC) status in the inguinal lymph nodes of uninfected mice. Tissues were taken 3 days after injection with polyclonal human immunoglobulin G (hu-Ig) (control) or LTβR-Ig, and adjacent frozen sections were stained with the FDC-specific monoclonal antiserum FDC-M2 (top row; red) and 8C12 antiserum to detect CD35 (bottom row; red). Expression of FDC-M2 and CD35 were undetectable in inguinal lymph nodes after treatment with LTβR-Ig. All sections were counterstained with haematoxylin (blue). Original magnification × 200.
Figure 2
Figure 2
Effect of treatment with lymphotoxin β-receptor immunoglobulin (LTβR-Ig) on the early accumulation of PrPSc in the draining inguinal lymph node and in the spleen. Mice were given a single intraperitoneal (i.p.) injection of LTβR-Ig or polyclonal human immunoglobulin G (hu-Ig) (control) 42 days after inoculation with scrapie via skin scarification on the right thigh. Tissues from two mice from each group were collected 3 days after treatment, and PrPSc accumulations were determined by paraffin-embedded tissue (PET) immunoblotting. Abundant PrPSc accumulations were detected in the lymphoid follicles of polyclonal human immunoglobulin G (hu-Ig)-treated animals (a and c, dark staining, arrowheads). In contrast, PrPSc accumulations were undetectable in tissues from LTβR-Ig-treated mice (b and d). Terminally scrapie affected brain tissue (e) and uninfected normal brain tissue (f) were included as controls to confirm the specificity of PrPSc detection.
Figure 3
Figure 3
Immunohistological analysis of brain tissue from mice treated with polyclonal human immunoglobulin G (hu-Ig) (control) or with lymphotoxin β-receptor immunoglobulin (LTβR-Ig) 3 days before scrapie inoculation by skin scarification. Large disease-specific PrP accumulations (upper row; brown), and reactive astrocytes expressing high levels of glial fibrillary acid protein (GFAP) (middle row; red) and spongiform pathology (haematoxylin & eosin, lower row) were detected in the hippocampi of all mice showing clinical signs of scrapie. In contrast, in the brains of LTβR-Ig-treated mice that remained free of the clinical signs of disease, no evidence of PrP accumulation, reactive astrocytes or spongiform pathology was detected 480 days after inoculation. All sections were counterstained with haematoxylin (blue). Original magnification × 200. dpi, days postinoculation on which the tissues were analysed; pos., mice that developed clinical signs of scrapie; neg., mice that were free of the clinical signs of scrapie.

Similar articles

Cited by

References

    1. Duffy P, Wolf J, Collins G, DeVoe AG, Streffin B, Cowen D. Possible person to person transmission of Creutzfeldt–Jacob disease. N Engl J Med. 1974;290:692. - PubMed
    1. Llewelyn CA, Hewitt PE, Knight RSG, Amar K, Cousens S, Mackenzie J, Will RG. Possible transmission of variant Creutzfeldt–Jakob disease by blood transfusion. Lancet. 2004;363:417–21. 10.1016/S0140-6736(04)15486-X. - DOI - PubMed
    1. Peden AH, Head MW, Ritchie DL, Bell JE, Ironside JW. Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet. 2004;354:527–9. 10.1016/S0140-6736(04)16811-6. - DOI - PubMed
    1. Taylor DM, McConnell I, Fraser H. Scrapie infection can be established readily through skin scarification in immunocompetent but not immunodeficient mice. J Gen Virol. 1996;77:1595–9. - PubMed
    1. Bartz JC, Kincaid AE, Bessen RA. Rapid prion neuroinvasion following tongue infection. J Virol. 2003;77:583–91. - PMC - PubMed

Publication types